Relay Therapeutics, Inc. (RLAY)
18.38
-0.39
(-2.08%)
USD |
NASDAQ |
Aug 31, 16:00
18.06
-0.32
(-1.74%)
After-Hours: 07:17
Relay Therapeutics Total Long Term Debt (Quarterly) : 26.64M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.64M |
| March 31, 2026 | 27.68M |
| December 31, 2025 | 28.69M |
| September 30, 2025 | 29.69M |
| June 30, 2025 | 30.66M |
| March 31, 2025 | 41.23M |
| December 31, 2024 | 42.78M |
| September 30, 2024 | 44.29M |
| June 30, 2024 | 45.76M |
| March 31, 2024 | 47.16M |
| December 31, 2023 | 48.50M |
| September 30, 2023 | 49.82M |
| June 30, 2023 | 51.10M |
| March 31, 2023 | 52.31M |
| December 31, 2022 | 53.47M |
| Date | Value |
|---|---|
| September 30, 2022 | 54.60M |
| June 30, 2022 | 20.02M |
| March 31, 2022 | 20.56M |
| December 31, 2021 | 21.06M |
| September 30, 2021 | 21.54M |
| June 30, 2021 | 22.02M |
| March 31, 2021 | 22.48M |
| December 31, 2020 | 22.90M |
| September 30, 2020 | 22.48M |
| June 30, 2020 | 22.87M |
| March 31, 2020 | 23.24M |
| December 31, 2019 | 23.58M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| AbbVie, Inc. | 70.82B |
| TG Therapeutics, Inc. | 752.53M |
| Karyopharm Therapeutics, Inc. | 255.12M |
| Krystal Biotech, Inc. | 7.045M |
| Akebia Therapeutics, Inc. | 209.81M |